Evolent Health, Inc.
EVHUS売上高
$1.9B
百万USD
営業利益
$-410M
百万USD
純利益
$-535M
百万USD
ROE
-128.7%
最新FY
EPS
$-5.07
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q2 | - | - | $-0.11 |
| FY2021 | Q3 | - | - | $-0.15 |
| FY2021 | FY | - | - | $-0.44 |
| FY2022 | Q1 | $297M | $-5M | $-0.06 |
| FY2022 | Q2 | $320M | $-5M | $-0.05 |
| FY2022 | Q3 | $353M | $2M | $0.02 |
| FY2022 | FY | $1.4B | $-19M | $-0.20 |
| FY2023 | Q1 | $428M | $-26M | $-0.24 |
| FY2023 | Q2 | $469M | $-34M | $-0.37 |
| FY2023 | Q3 | $511M | $-25M | $-0.30 |
| FY2023 | FY | $2.0B | $-113M | $-1.28 |
| FY2024 | Q1 | $640M | $-17M | $-0.22 |
| FY2024 | Q2 | $647M | $2M | $-0.06 |
| FY2024 | Q3 | $621M | $-23M | $-0.27 |
| FY2024 | FY | $2.6B | $-62M | $-0.81 |
| FY2025 | Q1 | $484M | $-65M | $-0.63 |
| FY2025 | Q2 | $444M | $-20M | $-0.44 |
| FY2025 | Q3 | $480M | $-21M | $-0.24 |
| FY2025 | FY | $1.9B | $-535M | $-5.07 |
| FY2026 | Q1 | $496M | $-27M | $-0.24 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $627M | $846M | $1.0B | - | $1.4B | $2.0B | $2.6B | $1.9B |
| 営業利益 | $-237M | $-73M | $-47M | $-307M | $-271M | $-42M | $4M | $-71M | $-40M | $-410M |
| 純利益 | $-160M | $-61M | $-53M | $-302M | $-334M | - | $-19M | $-113M | $-62M | $-535M |
| 総資産 | $1.2B | $1.3B | $1.7B | $1.5B | $1.4B | $1.4B | $1.8B | $2.7B | $2.5B | $1.9B |
| 純資産 | $912M | $1.0B | $1.2B | $929M | $620M | $694M | - | - | - | - |
| 自己資本 | $703M | $1.0B | $1.1B | $922M | $620M | $694M | $859M | $1.1B | $1.0B | $415M |
| 営業CF | $-36M | $-28M | $-21M | $-43M | $-16M | $39M | $-12M | $143M | $19M | $39M |
| EPS | $-3.55 | $-0.94 | - | - | - | $-0.44 | $-0.20 | $-1.28 | $-0.81 | $-5.07 |
| BPS | - | - | - | $10.89 | $7.20 | $7.64 | $7.74 | $9.25 | $8.59 | $3.72 |
| ROE | -22.7% | -6.0% | -4.6% | -32.7% | -53.9% | - | -2.2% | -10.6% | -6.2% | -128.7% |